Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
AssigneePrecisionBiotics Group Limited
InventorsBarry Kiely, Liam O'Mahony, David Groeger
Life of this patent
Estimating the term…
Abstract
An isolated strain of Bifidobacterium longum NCIMB 42020 is useful for the treatment of viral infections, especially viral respiratory infections such as influenza, rhinovirus and RSV. Bifidobacterium longum NCIMB 42020 is also useful for clearing secondary bacterial infections.
Claims9
A formulation for oral consumption by a subject, the formulation comprising a Bifidobacterium longum strain having the accession number NCIMB 42020 and an ingestible carrier, wherein the formulation is in the form of a tablet.
A formulation for oral consumption by a subject, the formulation comprising a Bifidobacterium longum strain having the accession number NCIMB 42020 and an ingestible carrier, wherein the strain is in the form of a freeze-dried powder or a bacterial broth.
Dependencies are inferred from the claim text.